13 Mar, EOD - Indian

Nifty IT 36122.5 (-0.52)

Nifty Smallcap 100 14897.35 (-0.98)

Nifty Pharma 20386.85 (-0.18)

Nifty Midcap 100 48125.1 (-0.75)

Nifty 50 22397.2 (-0.33)

Nifty Bank 48060.4 (0.01)

Nifty Next 50 58976.1 (-0.51)

SENSEX 73828.91 (-0.27)

13 Mar, EOD - Global

NIKKEI 225 37053.1 (0.72)

HANG SENG 23959.98 (2.12)

S&P 5640.75 (1.83)

LOGIN HERE

companylogoWelspun Specialty Solutions Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 500365 | NSE Symbol : REMIMETAL | ISIN : INE731F01037 | Industry : Steel - Medium / Small |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
18-Feb-2025 24-Feb-2025 Right Issue Welspun Specialty Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/02/2025 inter alia to consider and approve at a scheduled meeting of the Rights Issue Committee the rights issue price and related payment mechanism right entitlement ratio the record date timing of the rights issue and other related matters. Welspun Specialty Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/02/2025 ,inter alia, to consider and approve The Meeting of the Rights Issue Committee scheduled to be held on Friday, February 21, 2025, is being postponed to Monday, February 24, 2025. Please take the same on your record. (As per BSE Announcement Dated on 20/02/2025) Board considered and approved the following terms of the Rights Issue: a) Total number of Rights Equity Shares and Rights Issue size: 13,25,22,289 Rights Equity Shares each for an amount aggregating upto Rs.349.86 crores (assuming full subscription). b) Rights Issue Price: Rs.26.40 per Rights Equity Share (including a premium of ?20.40 per Rights Equity Share) c) Record date: March 01, 2025* (*Revised from February 27, 2025 to March 1, 2025 in compliance with the SEBI (LODR) Regulations, 2015 and SEBI (ICDR) Regulations, 2018) d) Rights Issue period: i. Rights Issue Opening Date: Monday, March 10, 2025; ii. Rights Issue Closing Date: Wednesday, March 19, 2025; iii. On-market renunciation period: Monday, March 10, 2025 to Thursday, March 13, 2025; iv. Off-market renunciation: It is noted that the eligible equity shareholders will have to ensure that renunciation through off-market transfers is completed in such a manner that the rights entitlements are credited to the demat account of the Renouncee on or prior to the Issue Closing Date. e) Outstanding Equity Shares: i. Prior to the Rights Issue: 53,00,89,156 equity shares of the Company. ii. Post Rights Issue#: 66,26,11,445 equity shares of the Company. #Assuming full subscription. f) Other terms of the Rights Issue: To be included in the Letter of Offer to be filed by the Company. g) Rights entitlement ratio and fractional entitlements: The Rights Equity Shares are being offered on a rights basis to Eligible Equity Shareholders in the ratio of 1 (One) Equity Share(s) for every 4 (Four) Equity Shares held on the Record Date. For Equity Shares being offered on a rights basis under this Issue, if the shareholding of any of the Eligible Equity Shareholders is less than 4 (Four) Equity Shares or not in the multiple of 4 (Four), the fractional entitlement of such Eligible Equity Shareholders shall be ignored in the computation of the Rights Entitlement. However, the Eligible Equity Shareholders whose fractional entitlements are being ignored, will be given preferential consideration for the allotment of one additional Equity Share each if they apply for additional Equity Shares over and above their Rights Entitlement, if any, subject to availability of Rights Equity Shares in this Issue post allocation towards Rights Entitlements applied for. Further, the Eligible Equity Shareholders holding less than 4 (Four) Equity Shares as on Record Date shall have zero' entitlement in the Issue. Such Eligible Equity Shareholders are entitled to apply for additional Equity Shares and will be given preference in the allotment of one additional Equity Share if, such Eligible Equity Shareholders apply for the additional Equity Shares. However, they cannot renounce the same in favour of third parties and the application forms shall be non- negotiable. h) ISIN for Rights Entitlement: INE731F20011 (As Per BSE Announcement Dated on 24.02.2025)
07-Feb-2025 12-Feb-2025 Redemption Welspun Specialty Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 ,inter alia, to consider and approve Intimation of the Board meeting is attached. The Board Meeting to be held on 12/02/2025 Stands Cancelled. (As Per BSE Announcement Dated on: 11.02.2025)
22-Jan-2025 27-Jan-2025 Quarterly Results Welspun Specialty Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/01/2025 inter alia to consider and approve unaudited financial results for the quarter and nine months ended December 31 2024 and consider and approve proposal of raising of funds. Outcome of the Board meeting is attached. The Board of Directors has, inter-alia, approved raising of funds by way of issuance of equity shares face value of Rs.6/-each (at such premium to be decided by the Baord / Rights Issue Committee) through Rights Issue for an aggregate amount not exceeding Rs.350 Crores to the eligiblie Shareholders of the Company in accordance with applicable laws and subject to regulatory approvals as may be required. (As Per BSE Announcement Dated on: 27/01/2025) Intimation for determining the record date for Rights Issue. (As Per BSE Announcement Dated on: 18/02/2025)
19-Dec-2024 19-Dec-2024 Change in Other Executives Mr. Navin Agarwal has been appointed as Chief Financial Officer of the Company. Mr. Brijveer Singh has resigned as Chief Financial Officer of the Company.
09-Nov-2024 13-Nov-2024 Raising funds through Debt Instr. Welspun Specialty Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2024 inter alia to consider and approve the proposal for fund raising by way of equity shares or other securities through rights issue qualified institutions placement preferential issue or any other method as may be permitted under the applicable law subject to such regulatory or statutory approvals as may be required. Outcome of the Board meeting is attached. Please take the same on records. (As Per BSE Announcement Dated on 13.11.2024)
16-Oct-2024 22-Oct-2024 Quarterly Results Welspun Specialty Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/10/2024 inter alia to consider and approve unaudited financial results for the quarter and half year ended September 30 2024. Outcome of the Board Meeting is attached Unaudited Financial Results for the quarter and half year ended Sept 30, 2024 is attached. (As Per BSE Announcement Dated on 22.10.2024)
27-Aug-2024 27-Aug-2024 Others The Board of Directors has, inter-alia, approved reclassification of authorised share capital and consequent alteration of Memorandum of Association of the Company subject to the approval of the Members. Read less..
16-Jul-2024 23-Jul-2024 Quarterly Results Welspun Specialty Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/07/2024 inter alia to consider and approve the unaudited financial results of the Company for the quarter ended June 30 2024. Outcome of the Board Meeting is attached. (As Per BSE Announcement dated on 23.07.2024)
19-Apr-2024 26-Apr-2024 Quarterly Results Welspun Specialty Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/04/2024 inter alia to consider and approve the audited financial results of the Company for the quarter and year ended March 31 2024. Take further notice that with reference to the above meeting of the Board of Directors the trading window for dealing in the securities of the Company by the Insiders/Designated Persons as defined under the SEBI (Prohibition of Insider Trading) Regulations 2015 is closed from Monday April 1 2024 till 48 hours after declaration of the results. Submission of audited financial results for the quarter and year ended March 31, 2024. (As Per BSE Announcement Dated on: 26/04/2024)
18-Jan-2024 25-Jan-2024 Quarterly Results Welspun Specialty Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/01/2024 inter alia to consider and approve the unaudited financial results for the quarter and nine months ended December 31 2023. In terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'), we wish to inform that the Board of Directors of the Company, at its meeting held today i.e. on Thursday, January 25, 2024, inter-alia, considered and unanimously approved the unaudited financial results of the Company for the quarter and nine months ended December 31, 2023. The said Unaudited Financial Results along with the Limited Review Report of the Statutory Auditors thereon are enclosed herewith in terms of Regulation 33 of the SEBI Listing Regulations. The Board meeting commenced at 12.00 noon and concluded at 2.30 p.m. Kindly take the same on your record. Please find attached unaudited financial results for the quarter and nine months ended December 31, 2023. (As per BSE Announcement Dated on 25/01/2024)
20-Oct-2023 27-Oct-2023 Quarterly Results Welspun Specialty Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2023 inter alia to consider and approve the unaudited financial results for the quarter and half year ended September 30 2023. Take further notice that with reference to the above meeting of the Board of Directors the trading window for dealing in the securities of the Company by the Insiders/Designated Persons as defined under the SEBI (Prohibition of Insider Trading) Regulations 2015 is closed from Sunday October 1 2023 till 48 hours after declaration of the results. Kindly take note of the above. In terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'), we wish to inform that the Board of Directors of the Company, at its meeting held today i.e. on Friday, October 27, 2023, inter-alia, considered and approved the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2023. The said Unaudited Financial Results along with the Limited Review Report of the Statutory Auditors thereon are enclosed herewith in terms of Regulation 33 of the SEBI Listing Regulations. The Board meeting commenced at 12.00 noon and concluded at 3.10 p.m. Please find attached herewith unaudited financial results for the quarter and half year ended September 30, 2023. (As per BSE Announcement Dated on 27/10/2023)
20-Jul-2023 27-Jul-2023 Quarterly Results Welspun Specialty Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2023 inter alia to consider and approve Please be informed that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday July 27 2023 inter alia to consider and approve the unaudited financial results of the Company for the quarter ended June 30 2023. Take further notice that with reference to the above meeting of the Board of Directors the trading window for dealing in the securities of the Company by the Insiders/Designated Persons as defined under the SEBI (Prohibition of Insider Trading) Regulations 2015 is closed from Saturday July 1 2023 till 48 hours after declaration of the results. Kindly take note of the above. In terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'), we wish to inform that the Board of Directors of the Company, at its meeting held today i.e. on Thursday, July 27, 2023, inter-alia, considered and approved the Unaudited Financial Results of the Company for the quarter ended June 30, 2023. The said Unaudited Financial Results along with the Limited Review Report of the Statutory Auditors thereon are enclosed herewith in terms of Regulation 33 of the SEBI Listing Regulations. The Board meeting commenced at 12.00 noon and concluded at 1:45 p.m. Kindly take the same on your record. Results-Financial Results for June 30, 2023 is attached. Please take the same on your records. (As Per BSE Announcement Dated on 27.07.2023)
17-May-2023 24-May-2023 Accounts Welspun Specialty Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2023 inter alia to consider and approve Please be informed that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday May 24 2023 inter alia to consider and approve the audited financial results of the Company for the quarter and year ended March 31 2023. Take further notice that with reference to the above meeting of the Board of Directors the trading window for dealing in the securities of the Company by the Insiders/Designated Persons as defined under the SEBI (Prohibition of Insider Trading) Regulations 2015 is closed from Saturday April 1 2023 till 48 hours after declaration of the results. Kindly take note of the above. In continuation of the announcement made on the captioned subject, we inadvertently missed out to submit the Auditors' Report on the audited financial results for the quarter and year ended March 31, 2023. Therefore, we are again submitting the Audited Financial Results along with the Report of the Statutory Auditors thereon and a declaration by the Chief Financial Officer of the Company with respect to unmodified opinion in terms of Regulation 33 of the SEBI Listing Regulations. The Board meeting commenced at 12.30 p.m. and concluded at 3.45 p.m. Kindly take the same on your record. In terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'), we wish to inform that the Board of Directors of the Company at its meeting held today i.e. on Wednesday, May 24, 2023, inter-alia, has considered and approved: 1. The Audited Financial Statements of the Company for the financial year ended March 31, 2023. 2. The Audited Financial Results of the Company for the quarter and year ended March 31, 2023. The said Audited Financial Results along with the Report of the Statutory Auditors thereon and a declaration by the Chief Financial Officer of the Company with respect to unmodified opinion, are enclosed herewith in terms of Regulation 33 of the SEBI Listing Regulations. The Board meeting commenced at 12.30 p.m. and concluded at 3.45 p.m. Kindly take the same on your record. (As Per BSE Announcement Dated on 24.05.2023)
23-Jan-2023 30-Jan-2023 Quarterly Results Welspun Specialty Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2023 inter alia to consider and approve Please be informed that a meeting of the Board of Directors of the Company is scheduled to be held on Monday January 30 2023 inter alia to consider and approve the unaudited financial results of the Company for the quarter and nine months ended December 31 2022. Take further notice that with reference to the above meeting of the Board of Directors the trading window for dealing in the securities of the Company by the Designated Persons as defined under the SEBI (Prohibition of Insider Trading) Regulations 2015 is closed from Sunday January 1 2023 till 48 hours after declaration of the results. Kindly take note of the above. In terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'), we wish to inform that the Board of Directors of the Company, at its meeting held today i.e. on Monday, January 30, 2023, inter-alia, considered and approved the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2022. The said Unaudited Financial Results along with the Limited Review Report of the Statutory Auditors thereon are enclosed herewith in terms of Regulation 33 of the SEBI Listing Regulations. Please also find attached the Business update for the quarter and nine months ended December 31, 2022. The Board meeting commenced at 04.30 p.m. and concluded at 07:00 p.m. Kindly take the same on your record. (As Per BSE Announcement dated on 30.01.2023)
21-Oct-2022 31-Oct-2022 Quarterly Results Welspun Specialty Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2022 inter alia to consider and approve Please be informed that a meeting of the Board of Directors of the Company is scheduled to be held on Monday October 31 2022 inter alia to consider and approve the unaudited financial results of the Company for the quarter and half year ended September 30 2022. Take further notice that with reference to the above meeting of the Board of Directors the trading window for dealing in the securities of the Company by the Designated Persons as defined under the SEBI (Prohibition of Insider Trading) Regulations 2015 is closed from Saturday October 1 2022 till 48 hours after declaration of the results. Kindly take note of the above. Please find attached outcome of the Board Meeting. Please find attached the Unaudited Financial Results of the Company for the quarter and the half year ended September 30, 2022. The said Unaudited Financial Results along with the Limited Review Report of the Statutory Auditors thereon are enclosed herewith in terms of Regulation 33 of the SEBI Listing Regulations. Mr. Narendra Kumar Bhandari ceased to be the Chief Financial Officer with effect from October 31, 2022. Mr. Brijveer Singh has been appointed as the Chief Financial Officer of the Company with effect from October 31, 2022 Mr. Suhas Pawar has been appointed as the Company Secretary & Compliance Officer of the Company with effect from October 31, 2022. (As Per BSE Announcement Dated on 31.10.2022)
1 2 

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

The power of the database is harnessed by our fired-up reporters to generate interesting ideas. The reader-friendly presentation of the idea, supplemented by relevant data and information, can be accessed online through Capita Telefolio and Telefolio Gold. These ideas are used by individual investors as well as institutional investors to do further research and stay ahead.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +